Rumour has it: It takes 10-15 years to bring a new therapy to the patients. Only 1% of all scientific ideas make it to the market - is another statistical fact.
How do those people who made developing novel therapies their mission make money on their way?
In this episode, I have the huge pleasure to chat with Thomas Schirrmann. He has profound experience in starting companies from scratch, walking through the ups and downs of Death Valley, and turn it into a commercial success.
Listen to his insights in creating and developing life science companies.
Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Thomas Schirrmann (https://www.linkedin.com/in/thomas-schirrmann-45a64183/)
Companies:
Corrat Therapeutics
CS Life Science Invest (https://www.cslifescienceinvest.com)
Yumab (https://www.linkedin.com/company/yumab-gmbh/)
Do you want to learn more about life science?
Subscribe to our newsletter: https://mailchi.mp/e2467061ef75/lsg2g
Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)
Stada
Caring for people’s health as a trusted partner
#18: The Secrets of Life Science Business Models